Loading stock data…
HUM
$304.85+9.50 (+3.22%)
Pre-Market$303.99-0.86 (-0.28%)· Last close May 13
Humana Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Humana Inc. in the Healthcare sector is trading at $304.85. Wall Street consensus targets $243.71 (24 analysts), implying a -20.1% move over the next 12 months. The stock is currently near its 52-week high of $315.35, remaining 26.9% above its 200-day moving average. On fundamentals, Piotroski 3/9 flags weak fundamentals, Altman Z in the safe zone. The Whystock Score of 50/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Sell-side targets imply -20.1% downside over 12 months
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Sector + growth-aware fair-multiple estimate. Fair P/E = sector-anchor + (ROE × 25) + (max(revenue growth, earnings growth) × 30), capped at 1.6× sector. Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. The sector anchor (Tech ≈ 28, Comm Services ≈ 24, Utilities ≈ 18, Financials ≈ 14, etc.) keeps quality compounders from being mechanically penalized against utility multiples. Result is a normalised multiple gauge — not a price target.
Current Price$304.85
Potential Downside
2.8%
Whystock Fair Value$296.29
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Analyst Consensus24 analysts
Hold
Mean target$243.71-20.1%
Range$146.00 – $333.00
Fundamentals
Humana Inc. provides medical and specialty insurance products in the United States. It operates in two segments, Insurance and CenterWell. The Insurance segment offers individual Medicare Advantage products, including health insurance benefits, inclu...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$25.81B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
21.84
Beta
Defensive asset. Lower volatility than the S&P 500.
0.45
Div Yield
Strong income play. Yield provides a meaningful total return floor.
165.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
8.93%
Volume
Today's trading volume
2.64M
Recent News
2 Profitable Stocks with Exciting Potential and 1 We Turn Down
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.
Piper Sandler Just Hiked Humana Price Target to $254: Medicare Advantage Beat Powers the Bull Case
Humana (NYSE:HUM) stock received a price target raise to $254 from $182 from Piper Sandler, which maintained a Neutral rating. The move follows a Q1 2026 earnings beat driven by stronger Medicare Advantage performance and a favorable medical loss ratio (MLR). For prudent investors, the action signals that the longer-term margin recovery thesis is back in ... Piper Sandler Just Hiked Humana Price Target to $254: Medicare Advantage Beat Powers the Bull Case
The Silver Tsunami: Healthcare ETFs to Buy Amid Aging US Demographics
ETFs like XLV stand out as aging U.S. demographics fuel rising demand for healthcare, medical devices and senior-focused care.
S&P 500, Nasdaq end lower as inflation, Iran tensions weigh
By Stephen Culp and Ragini Mathur NEW YORK, May 12 (Reuters) - The S&P 500 and the Nasdaq closed lower on Tuesday, easing from record highs as hotter-than-expected inflation data and an increasingly
What Humana (HUM)'s Lowered 2026 EPS Outlook and Buybacks Mean For Shareholders
In late April 2026, Humana Inc. reported first‑quarter revenue of US$39,648 million and net income of US$1,186 million, completed a US$276.13 million share repurchase program, and lowered its full‑year 2026 GAAP diluted EPS guidance to at least US$8.36. Alongside its earnings update and guidance revision, Humana’s foundation released new research on under‑recognized mental health needs among Florida’s rapidly growing senior population, highlighting longer‑term care and cost pressures. We’ll...